Carmel Fratianni
Endocrinology, Diabetes & Metabolism · Media, PANPI 1033106828
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Lilly USA, LLC at 25.1% of the total. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in PA, where the typical reported total is $1,080.
Across 87 payments — averaging $15.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$338
- Medtronic$234
- Novo Nordisk$115
- Sanofi-aventis U.S. LLC$93
- AstraZeneca$83
- Xeris Pharmaceuticals, Inc.$69
- plus $417 from 13 others
What the payments were for
- Food & beverage$1,348100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 23 | $338 |
| Medtronic(2 entities) | 17 | $234 |
| Novo Nordisk | 8 | $115 |
| Sanofi-aventis U.S. LLC | 5 | $93 |
| AstraZeneca | 6 | $83 |
| Xeris Pharmaceuticals, Inc. | 4 | $69 |
| Merck | 4 | $62 |
| Abbott | 3 | $61 |
| Radius Health, Inc. | 3 | $49 |
| Amarin Pharma, Inc. | 3 | $49 |
| AbbVie | 2 | $45 |
| Amgen | 2 | $32 |
| Tandem Diabetes Care, Inc. | 1 | $25 |
| Insulet Corporation | 1 | $19 |
| IBSA Pharma Inc. | 1 | $17 |
| UCB, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
How this compares
$1,348 in reported general payments places this provider in the 50th percentile of 388 endocrinology, diabetes & metabolism providers in Pennsylvania.
See all endocrinology, diabetes & metabolism providers in Pennsylvania →
Other endocrinology, diabetes & metabolism in Media
- Serge JabbourPhiladelphia$1.2M
- Vijay BahlPittsburgh$998K
- Geraldo SaavedraWhitehall$698K
- Jane MayrinPhiladelphia$628K
- Stephan KowalykGreensburg$591K
- Matthew KaneWest Chester$577K
- Intekhab AhmedPhiladelphia$528K
- Swarna VarmaPittsburgh$520K
- James DickeHanover$425K
- Mitchell LazarPhiladelphia$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.